Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A

Our recent studies showed that schisantherin A (StA) is a promising candidate for PD treatment, but the pharmacokinetic profile of StA is largely unknown. The effects of different formulations on the pharmacokinetics and bioavailability of StA were investigated by HPLC equipped with a vacuum degasse...

Descripción completa

Detalles Bibliográficos
Autores principales: Sa, Fei, Guo, Bao Jian, Li, Sai, Zhang, Zai Jun, Chan, Hok Man, Zheng, Ying, Lee, Simon Ming Yuen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449939/
https://www.ncbi.nlm.nih.gov/pubmed/26075137
http://dx.doi.org/10.1155/2015/951361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449939/
https://www.ncbi.nlm.nih.gov/pubmed/26075137
http://dx.doi.org/10.1155/2015/951361

Ejemplares similares